NCT02269007View on ClinicalTrials.gov

A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

inactivated quadrivalent influenza vaccine (split virion)

0.5ml inactivated quadrivalent influenza vaccine (split virion) for each subject, one dose

Trial Locations (1)

Unknown

Guanyun County Center for Disease Control and Prevention, Liangyungang

All Listed Sponsors
collaborator

Jiangsu Jindike Biotechnology Co., Ltd.

INDUSTRY

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT02269007 - A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China | Biotech Hunter | Biotech Hunter